{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T21:07:50Z","timestamp":1778620070689,"version":"3.51.4"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,5]],"date-time":"2022-10-05T00:00:00Z","timestamp":1664928000000},"content-version":"vor","delay-in-days":4,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004896","name":"Eisai Incorporated","doi-asserted-by":"publisher","award":["GPP 2022"],"award-info":[{"award-number":["GPP 2022"]}],"id":[{"id":"10.13039\/501100004896","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003769","name":"Eisai Co Ltd","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003769","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","epilepsybehavior.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.yebeh.2022.108901","type":"journal-article","created":{"date-parts":[[2022,9,16]],"date-time":"2022-09-16T06:24:40Z","timestamp":1663309480000},"page":"108901","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Assessment of the long-term efficacy and safety of adjunctive perampanel in adolescent patients with epilepsy: Post hoc analysis of open-label extension studies"],"prefix":"10.1016","volume":"135","author":[{"given":"J. Eric","family":"Pi\u00f1a-Garza","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vicente","family":"Villanueva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Rosenfeld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harumi","family":"Yoshinaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Patten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manoj","family":"Malhotra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.yebeh.2022.108901_b0005","unstructured":"Institute of Medicine, Roundtable on Research and Development of Drugs, Biologics, and Medical Devices, Division of Health Sciences Policy, R.W. Estabrook, P. Bouxsein, S. Pitluck, J.R. Davis. Rational Therapeutics for Infants and Children: Workshop summary. Washington, D.C.: National Academies Press; 2000."},{"issue":"Suppl 3","key":"10.1016\/j.yebeh.2022.108901_b0010","doi-asserted-by":"crossref","first-page":"22","DOI":"10.5698\/1535-7511-12.4s.22","article-title":"AED treatment through different ages: as our brains change, should our drug choices also?","volume":"12","author":"French","year":"2012","journal-title":"Epilepsy Curr"},{"issue":"2","key":"10.1016\/j.yebeh.2022.108901_b0015","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1469-8749.1989.tb03976.x","article-title":"Effects of puberty on seizure frequency","volume":"31","author":"Niijima","year":"1989","journal-title":"Dev Med Child Neurol"},{"issue":"3","key":"10.1016\/j.yebeh.2022.108901_b0020","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1212\/01.WNL.0000048560.53624.AF","article-title":"Onset of epilepsy at the time of menarche","volume":"60","author":"Klein","year":"2003","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.yebeh.2022.108901_b0025","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1006\/ebeh.2000.0027","article-title":"Impact of taking antiepileptic drugs at school in a group of children and adolescents","volume":"1","author":"Anderson","year":"2000","journal-title":"Epilepsy Behav"},{"issue":"4","key":"10.1016\/j.yebeh.2022.108901_b0030","first-page":"220","article-title":"Social aspects of epilepsy in childhood and adolescence","volume":"24","author":"Buchanan","year":"1988","journal-title":"Aust Paediatr J"},{"issue":"s8","key":"10.1016\/j.yebeh.2022.108901_b0035","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1046\/j.1528-1157.42.s8.6.x","article-title":"Special needs of the adolescent with epilepsy","volume":"42","author":"Nordli","year":"2001","journal-title":"Epilepsia"},{"issue":"11","key":"10.1016\/j.yebeh.2022.108901_b0040","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1038\/aps.2012.135","article-title":"The effect of poor compliance on the pharmacokinetics of carbamazepine and its epoxide metabolite using Monte Carlo simulation","volume":"33","author":"Ding","year":"2012","journal-title":"Acta Pharmacol Sin"},{"issue":"4","key":"10.1016\/j.yebeh.2022.108901_b0045","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/S1525-5050(02)00037-9","article-title":"The relationship between poor medication compliance and seizures","volume":"3","author":"Cramer","year":"2002","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2022.108901_b0050","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.yebeh.2014.03.013","article-title":"The practical impact of altered dosing on perampanel plasma concentrations: Pharmacokinetic modeling from clinical studies","volume":"35","author":"Gidal","year":"2014","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2022.108901_b0055","unstructured":"European Medicines Agency. Fycompa\u00ae Annex I: Summary of Product Characteristics, https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/fycompa-epar-product-information_en.pdf; 2020 [February 4, 2021]."},{"key":"10.1016\/j.yebeh.2022.108901_b0060","unstructured":"Food and Drug Administration (FDA). FYCOMPA\u00ae Prescribing Information, September 2020, https:\/\/www.fycompa.com\/-\/media\/Files\/Fycompa\/Fycompa_Prescribing_Information.pdf; [February 11, 2021]."},{"issue":"6","key":"10.1016\/j.yebeh.2022.108901_b0065","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1212\/WNL.0b013e3182635735","article-title":"Adjunctive perampanel for refractory partial-onset seizures: Randomized phase III study 304","volume":"79","author":"French","year":"2012","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.yebeh.2022.108901_b0070","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1528-1167.2012.03638.x","article-title":"Evaluation of adjunctive perampanel in patients with refractory partial-onset seizures: Results of randomized global phase III study 305","volume":"54","author":"French","year":"2013","journal-title":"Epilepsia"},{"issue":"18","key":"10.1016\/j.yebeh.2022.108901_b0075","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1212\/WNL.0b013e318254473a","article-title":"Randomized phase III study 306: Adjunctive perampanel for refractory partial-onset seizures","volume":"78","author":"Krauss","year":"2012","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.yebeh.2022.108901_b0080","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/epi.13279","article-title":"Cognitive effects of adjunctive perampanel for partial-onset seizures: A randomized trial","volume":"57","author":"Meador","year":"2016","journal-title":"Epilepsia"},{"issue":"4","key":"10.1016\/j.yebeh.2022.108901_b0085","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/ane.12883","article-title":"Adjunctive perampanel in partial-onset seizures: Asia-Pacific, randomized phase III study","volume":"137","author":"Nishida","year":"2018","journal-title":"Acta Neurol Scand"},{"issue":"11","key":"10.1016\/j.yebeh.2022.108901_b0090","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1212\/WNL.0000000000001930","article-title":"Perampanel for tonic-clonic seizures in idiopathic generalized epilepsy: A randomized trial","volume":"85","author":"French","year":"2015","journal-title":"Neurology"},{"issue":"Pt A","key":"10.1016\/j.yebeh.2022.108901_b0095","doi-asserted-by":"crossref","first-page":"106876","DOI":"10.1016\/j.yebeh.2019.106876","article-title":"Efficacy and safety of adjunctive perampanel in adolescent patients with epilepsy: Post hoc analysis of six randomized studies","volume":"104","author":"Pi\u00f1a-Garza","year":"2020","journal-title":"Epilepsy Behav"},{"issue":"7","key":"10.1016\/j.yebeh.2022.108901_b0100","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1111\/epi.16573","article-title":"Assessment of the long-term efficacy and safety of adjunctive perampanel in tonic-clonic seizures: Analysis of four open-label extension studies","volume":"61","author":"Rektor","year":"2020","journal-title":"Epilepsia"},{"issue":"7","key":"10.1016\/j.yebeh.2022.108901_b0105","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1111\/epi.12643","article-title":"Long-term safety of perampanel and seizure outcomes in refractory partial-onset seizures and secondarily generalized seizures: results from phase III extension study 307","volume":"55","author":"Krauss","year":"2014","journal-title":"Epilepsia"},{"issue":"4","key":"10.1016\/j.yebeh.2022.108901_b0110","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1111\/epi.14044","article-title":"Final safety, tolerability, and seizure outcomes in patients with focal epilepsy treated with adjunctive perampanel for up to 4 years in an open-label extension of phase III randomized trials: Study 307","volume":"59","author":"Krauss","year":"2018","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2022.108901_b0115","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.yebeh.2018.03.029","article-title":"Long-term effects of adjunctive perampanel on cognition in adolescents with partial seizures","volume":"83","author":"Pi\u00f1a-Garza","year":"2018","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2022.108901_b0120","doi-asserted-by":"crossref","first-page":"108528","DOI":"10.1016\/j.yebeh.2021.108528","article-title":"Sustained seizure freedom with adjunctive perampanel in patients with convulsive seizures: Post hoc analysis of open-label extension studies 307 and 332","volume":"128","author":"Resnick","year":"2022","journal-title":"Epilepsy Behav"},{"issue":"4","key":"10.1016\/j.yebeh.2022.108901_b0125","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1177\/08830738211047665","article-title":"PROVE\u2014Phase IV study of perampanel in real-world clinical care of patients with epilepsy: Interim analysis in pediatric patients","volume":"37","author":"Segal","year":"2022","journal-title":"J Child Neurol"},{"key":"10.1016\/j.yebeh.2022.108901_b0130","unstructured":"Wehner T. Generalized Tonic-Clonic Seizures. In: Wyllie E, editor. Treatment of Epilepsy: Principles and Practice. 5th Ed. Philadelphia: Wolters Kluwer\/Lippincott Williams & Wilkins. 5th ed; 2011, p. 184-91."},{"issue":"Suppl 9","key":"10.1016\/j.yebeh.2022.108901_b0135","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1528-1167.2005.00325.x","article-title":"Seizure aggravation in idiopathic generalized epilepsies","volume":"46","author":"Chaves","year":"2005","journal-title":"Epilepsia"},{"issue":"Suppl 3","key":"10.1016\/j.yebeh.2022.108901_b0140","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1528-1167.2009.02042.x","article-title":"Drug treatment of epilepsy in the century of the ILAE: The second 50 years, 1959\u20132009","volume":"50","author":"Shorvon","year":"2009","journal-title":"Epilepsia"},{"issue":"Pt 5","key":"10.1016\/j.yebeh.2022.108901_b0145","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1093\/brain\/awl047","article-title":"Absence and myoclonic status epilepticus precipitated by antiepileptic drugs in idiopathic generalized epilepsy","volume":"129","author":"Thomas","year":"2006","journal-title":"Brain"},{"issue":"11","key":"10.1016\/j.yebeh.2022.108901_b0150","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1111\/j.1528-1167.2007.01210.x","article-title":"Aggravation of seizures and\/or EEG features in children treated with oxcarbazepine monotherapy","volume":"48","author":"Vendrame","year":"2007","journal-title":"Epilepsia"},{"issue":"3","key":"10.1016\/j.yebeh.2022.108901_b0155","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1124\/pr.115.012021","article-title":"Epilepsy, antiepileptic drugs, and aggression: an evidence-based review","volume":"68","author":"Brodie","year":"2016","journal-title":"Pharmacol Rev"},{"issue":"8","key":"10.1016\/j.yebeh.2022.108901_b0160","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1111\/epi.13054","article-title":"Psychiatric and behavioral adverse events in randomized clinical studies of the noncompetitive AMPA receptor antagonist perampanel","volume":"56","author":"Ettinger","year":"2015","journal-title":"Epilepsia"},{"issue":"9","key":"10.1016\/j.yebeh.2022.108901_b0165","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1001\/jamaneurol.2021.2480","article-title":"Suicidality risk of newer antiseizure medications: A meta-analysis","volume":"78","author":"Klein","year":"2021","journal-title":"JAMA Neurol"},{"issue":"3","key":"10.1016\/j.yebeh.2022.108901_b0170","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1001\/2013.jamapsychiatry.55","article-title":"Prevalence, correlates, and treatment of lifetime suicidal behavior among adolescents: Results from the National Comorbidity Survey Replication Adolescent Supplement","volume":"70","author":"Nock","year":"2013","journal-title":"JAMA Psychiatry"},{"issue":"8","key":"10.1016\/j.yebeh.2022.108901_b0175","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1111\/j.1742-1241.2008.01808.x","article-title":"The impact of analytic method on interpretation of outcomes in longitudinal clinical trials","volume":"62","author":"Prakash","year":"2008","journal-title":"Int J Clin Pract"},{"issue":"2","key":"10.1016\/j.yebeh.2022.108901_b0180","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1177\/1740774515602688","article-title":"Fallacies of last observation carried forward analyses","volume":"13","author":"Lachin","year":"2016","journal-title":"Clin Trials"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152550502200350X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152550502200350X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T20:08:36Z","timestamp":1778616516000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152550502200350X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":36,"alternative-id":["S152550502200350X"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2022.108901","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessment of the long-term efficacy and safety of adjunctive perampanel in adolescent patients with epilepsy: Post hoc analysis of open-label extension studies","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2022.108901","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"108901"}}